Health Care and Biotech
Alcidion’s IT Targets Hospital Efficiency
Alcidion is an emerging operator in the field of hospital IT, with technology that can reduce deaths attributable to medical error. The stock price has doubled since it listed on ASX in February this year.
Dec 19 2016
Estia Health Beset By Uncertainty
Estia Health is beset by uncertainty surrounding the sustainability of earnings and this is not expected to moderate in the near term.
Dec 13 2016
Rebound For Sirtex
Michael Gable of Fairmont Equities suggests technically, Sirtex Medical should be set to recover.
Dec 13 2016
Sirtex Reaction Overdone
Increased competition has wedged dose sales for Sirtex Medical but brokers suspect the market’s reaction is overdone.
Dec 12 2016
Previous Stories
Top Ten Weekly Recommendation, Target Price, Earnings Forecast Changes
Feb 06 2012
Weekly update on recommendation, target price, and earnings forecast changes.
Pharmaxis Upside Unappreciated
Jan 31 2012
Brokers argue the market is missing the upside opportunity of a likely major de-risking ahead for biotech Pharmaxis.
Two Major Biotech Trends In 2012
Jan 23 2012
Investment U’s Marc Lichtenfeld reports about major international developments for the biotech sector.
QRxPharma Unlocks Strategic Partnership Potential
Dec 22 2011
QRxPharma has signed a strategic partnership with Actavis and brokers are positive on the deal given the royalties to be received and the potential for further agreements to be signed.
The Short Report
Dec 21 2011
FNArena’s weekly update on short positions in the Australian share market.
Top Ten Weekly Recommendation, Target Price, Earnings Forecast Changes
Dec 19 2011
Weekly update on recommendation, target price, and earnings forecast changes.
Hearing Cochlear’s Call
Dec 15 2011
Despite making substantial net profit downgrades for the next few years, analysts at Macquarie are still hearing Cochlear’s call.
The Short Report
Dec 14 2011
FNArena’s weekly update on short positions in the Australian share market.
Bell Potter Remains Positive On Oz Life Sciences Stocks
Dec 13 2011
Bell Potter’s Life Sciences Index is well down this year but the broker continues to see value, offering its top picks in the sector.
The Short Report
Dec 07 2011
FNArena’s weekly update on short positions in the Australian share market.
Analyse The Market From A Different Angle
Latest News
| 1 |
The Market In Numbers – 5 Jul 2025Jul 05 2025 - Australia |
| 2 |
ASX Winners And Losers Of Today – 04-07-25Jul 04 2025 - Daily Market Reports |
| 3 |
Next Week At A Glance -7-11 Jul 2025Jul 04 2025 - Weekly Reports |
| 4 |
Weekly Top Ten News Stories – 4 July 2025Jul 04 2025 - Weekly Reports |
| 5 |
In Case You Missed It – BC Extra Upgrades & Downgrades – 04-07-25Jul 04 2025 - Weekly Reports |